Download Files:
Products Details
Product Description
– Lankacidin C is an inhibitor of protein synthesis in vitro. Lankacidin C inhibits the activity of L1210 leukemia, B16 melanoma and 6C3 HED/OG lymphosarcoma cell lines. Lankacidin C has antibacterial activity and antitumor activity[1][2].
Web ID
– HY-121412
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C25H33NO7
References
– [1]Cai L, et al. Modular Approaches to Lankacidin Antibiotics. J Am Chem Soc. 2020 Sep 2;142(35):15116-15126.|[2]Ootsu K, et al. Effects of Lankacidin group (T2636) antibiotics on the tumor growth and immune response against sheep erythrocytes in mice. Gan. 1973 Oct;64(5):481-92.
CAS Number
– 23623-31-6
Molecular Weight
– 459.53
SMILES
– C[C@@H]1[C@H]2C[C@H](O)/C=C/C(C)=C/C[C@H](O)/C=C/C(C)=C/[C@@H](NC(C(C)=O)=O)[C@@](C(O2)=O)(C)C1=O
Clinical Information
– No Development Reported
Research Area
– Cancer; Infection
Solubility
– 10 mM in DMSO
Target
– Antibiotic;Bacterial
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
